YDES

YD Bio Limited Ordinary Shares (YDES) Economic Moat Analysis (2026)

Invetso Score: 2.2/10 — Weak · Last Updated: 2026-08-01

Intangible Assets

No provided filing evidence shows proprietary brands, patents, or regulated IP that would let YDES sustain pricing power versus peers.

Negative TTM ROIC and ROCE indicate the company is not converting any presumed intangible advantage into durable excess returns, unlike stronger peers that monetize IP or brand.

With no 5-year profitability or margin history provided, there is no evidence of a repeatable intangible asset base that improves retention or margins over time.

Switching Costs

The available metrics do not show recurring revenue, embedded workflows, or contractual lock-in that would make customers costly to replace versus peers.

Zero cash conversion cycle and zero asset turnover do not, by themselves, demonstrate customer dependence or switching friction.

Compared with peers that benefit from integrated systems or mission-critical software, YDES has no evidence of retention advantages that would protect pricing over 5–10 years.

Network Effects

No evidence is provided of a user, data, or marketplace network that compounds value as adoption rises.

Negative returns on capital suggest any scale in the business is not yet translating into a self-reinforcing ecosystem advantage versus peers.

Absent filing or third-party evidence of platform dependency, YDES appears materially weaker than peers with proven network-driven retention.

Cost Advantage

Negative ROIC and ROCE imply YDES is not currently operating with a cost structure that beats peers on a durable basis.

No evidence is provided of lower input costs, superior process efficiency, or structural procurement advantages that would widen margins versus competitors.

Without margin history or scale evidence, there is no basis to conclude a persistent cost advantage that would defend pricing.

Efficient Scale

The data do not show a niche market position or capacity constraint that would allow YDES to serve a limited market more efficiently than peers.

Negative capital returns argue against a protected scale position that would deter entry or support superior economics.

Unlike peers in regulated or highly concentrated markets, YDES has no provided evidence of industry structure that would create efficient-scale protection.

Overall Score

YDES shows no provided evidence of durable moat drivers, and the negative TTM ROIC/ROCE reinforce that any competitive position is not yet translating into peer-leading pricing power, retention, or returns.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on YD Bio Limited Ordinary Shares. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →